Dixon Lab | UoN
@DixonLabNotts
Developing novel intracellular therapeutics using gene technologies and drugs | RMCT Division, Pharmacy, BDI, University of Nottingham
You might like
Cobra collaborates with Scancell on COVID-19 vaccine plasmids manufacturingchemist.com/news/article_p…
manufacturingchemist.com
Cobra collaborates with Scancell on COVID-19 vaccine plasmids
The collaboration will aim for GMP production of material for the Phase 1 clinical trial of Scancell’s DNA vaccine against SARS-CoV-2
Cobra Biologics to manufacture plasmids for Phase I clinical trial COVID-19 vaccine ddw-online.com/product-news/p… #COVID19
.@CobraBiologics, a CDMO and part of Cognate BioServices, and .@scancellpharma have entered into a collaboration for Cobra to manufacture Scancell’s #COVID19 vaccine. Learn more: ow.ly/wYjD50BHYN0
📢@CobraBiologics and @scancellpharma today announced that they have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine.💉👇
TODAY: Cobra Biologics selected to manufacture plasmids for clinical trial of @scancellpharma’s COVID-19 vaccine Read the press release in full >>> cobrabio.com/news/cobra-to-…
This is fantastic news - collaboration between Scancell, @UniofNottingham & @TrentUni for #COVID19 vaccine to clinical trials Delighted some of this stellar science will be done by researchers in the Biodiscovery Institute Story at nottingham.ac.uk/news/funding-f… #WeAreUoN
Scientists @UniofNottingham and @TrentUni are to begin clinical trials for a DNA vaccine to prevent #COVID19 -Working with @scancellpharma to adapt its existing cancer vaccine platform for the development of a new #vaccine #WeareUon #Unistogether #UoNNews ow.ly/gMoR50BavjN
🔴 News from our #COVID19 Live blog: 👉 UK awards £4M to two early stage COVID-19 vaccine projects from @VaccitechLtd and @scancellpharma. Read more ➡️ bit.ly/liveblog19
Scientists @UniofNottingham and @TrentUni are to begin clinical trials for a DNA vaccine to prevent #COVID19 -Working with @scancellpharma to adapt its existing cancer vaccine platform for the development of a new #vaccine #WeareUon #Unistogether #UoNNews ow.ly/gMoR50BavjN
Scancell-led consortium receives funding from @innovateuk and @UKRI_News for #COVID19 vaccine development @JonathanKBall @DixonLabNotts @JamesEdDixon @UniofNottingham @trentiuni
londonstockexchange.com/news-article/t… Delighted to see @UKRI_News @innovateuk #COVID19 vaccine funding for @scancellpharma with @UniofNottingham @TrentUni
@OpenOrphan @scancellpharma #ReNeuron @Parsotix. A brilliant evening of biotech and potential life savers from 6pm tonight at the @proactive_UK virtual forum. Join them. Join us. Join me
$SCLP Scancell Holdings consortium gets government backing for Covid trial tinyurl.com/y3dsvhh3 via @proactive_UK @scancellpharma #SCLP
Fantastic to see @scancellpharma receive @innovateuk funding to kick start clinical development of a COVID-19 #vaccine.💉
Scancell-led consortium receives funding from @innovateuk and @UKRI_News for #COVID19 vaccine development @JonathanKBall @DixonLabNotts @JamesEdDixon @UniofNottingham @trentiuni
BBC News - Coronavirus: Nottinghamshire woman, 75, 'first positive test within UK' bbc.co.uk/news/uk-englan…
bbc.co.uk
Coronavirus: Nottinghamshire woman, 75, 'first positive test within UK'
The woman is also believed by scientists to be the first in the UK to die after contracting Covid-19.
An RNA vaccine candidate for SARS-CoV-2, BNT162b1, is shown to induce a robust immune response in healthy adults aged 18–55 years in an interim report of a phase 1/2 clinical trial published in Nature. go.nature.com/2F8lQ2v
United States Trends
- 1. #PresidentsDay N/A
- 2. Bradley Chubb N/A
- 3. George Washington N/A
- 4. #MondayMotivation N/A
- 5. Good Monday N/A
- 6. #MondayVibes N/A
- 7. Happy Chinese New Year N/A
- 8. Dogs N/A
- 9. Cam Payne N/A
- 10. Washington's Birthday N/A
- 11. Ty France N/A
- 12. Trey Gowdy N/A
- 13. Jack Suwinski N/A
- 14. Kevin Nash N/A
- 15. Miss J N/A
- 16. Ashanti N/A
- 17. Happy Lunar New Year N/A
- 18. Orban N/A
- 19. .hack N/A
- 20. Steve Cohen N/A
Something went wrong.
Something went wrong.